NCT07589231 Effects of Carbon Fiber Insoles on CMJ and Sprint Performance
| NCT ID | NCT07589231 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Benjamín Cuenca Valero |
| Condition | Healthy |
| Study Type | INTERVENTIONAL |
| Enrollment | 38 participants |
| Start Date | 2025-10-30 |
| Primary Completion | 2026-06-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 38 participants in total. It began in 2025-10-30 with a primary completion date of 2026-06-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study evaluates the effects of VKTRY carbon fiber insoles on vertical jump and sprint performance in moderately active men. Participants will perform tests with and without insoles, assessing both objective performance and subjective perception using a Likert-type scale.
Eligibility Criteria
Inclusion Criteria: * Men aged 18-30 years * Moderate physical activity (2-4 times/week) * No injuries in the last 6 months Exclusion Criteria: * Use of orthoses or podiatric pathologies * Neurological or cardiovascular disease * Refusal to sign informed consent
Contact & Investigator
Benjamín Cuenca Valero
STUDY DIRECTOR
Universidad Católica de Valencia (UCV) Facultad de Medicina y Ciencias de la Salud. C/ Quevedo, 2 - 46001 Valencia
Frequently Asked Questions
Who can join the NCT07589231 clinical trial?
This trial is open to male participants only, aged 18 Years or older, up to 30 Years, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07589231 currently recruiting?
Yes, NCT07589231 is actively recruiting participants. Contact the research team at benjamin.cuenca@ucv.es for enrollment information.
Where is the NCT07589231 trial being conducted?
This trial is being conducted at Valencia, Spain.
Who is sponsoring the NCT07589231 clinical trial?
NCT07589231 is sponsored by Benjamín Cuenca Valero. The principal investigator is Benjamín Cuenca Valero at Universidad Católica de Valencia (UCV) Facultad de Medicina y Ciencias de la Salud. C/ Quevedo, 2 - 46001 Valencia. The trial plans to enroll 38 participants.